Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases.

Abdominal radiology (New York) - 1 Jun 2019

Mao Wujian, Zhou Jun, Zhang He, Qiu Lin, Tan Hui, Hu Yan, Shi Hongcheng

Abstract excerpt

PURPOSE: To investigate the association between metabolic parameters of dual time point 18F-FDG PET/CT imaging and Kirsten rat sarcoma (KRAS) mutation status in colorectal liver metastases (CRLM). METHODS: Forty-nine colorectal cancer patients with 87 liver metastatic lesions were included in this retrospective study. KRAS gene mutation tests were also performed for all the patients. The maximum standardized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Colorectal Neoplasms
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Mutation

Share to Positron Emission Tomography Computed Tomography

Share to Proto-Oncogene Proteins p21(ras)

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 30143816
DOI: 10.1007/s00261-018-1740-8

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases.PMID 30143816Read ↗

Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.Semantic proximity Read ↗

Correlation between KRAS mutation and 18F-FDG uptake in stage IV colorectal cancer.Semantic proximity Read ↗

The adiposity of CRLM before targeted therapy initiation may serve as a marker to distinguish KRAS mutation status：A retrospective studySemantic proximity Read ↗

Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study.Semantic proximity Read ↗

18 F-FDG uptake heterogeneity predicts KRAS/NRAS/BRAF mutation status in patients with liver metastases of colorectal cancerSemantic proximity Read ↗

Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.Semantic proximity Read ↗

Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.Semantic proximity Read ↗

Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.Semantic proximity Read ↗

Pretreatment 18F-FDG PET/CT Imaging Predicts the KRAS/NRAS/BRAF Gene Mutational Status in Colorectal CancerSemantic proximity Read ↗

Correlations among KRAS Mutation, Microsatellite Instability, and 18F-FDG Uptake in Colon Cancer.Semantic proximity Read ↗

Development and Validation of Radiomics Signatures to Predict KRAS Mutation Status Based on Triphasic Enhanced Computed Tomography in Patients with Colorectal CancerSemantic proximity Read ↗

From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.